These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12876957)

  • 21. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.
    Schmidt CJ; Kehne JH; Carr AA; Fadayel GM; Humphreys TM; Kettler HJ; McCloskey TC; Padich RA; Taylor VL; Sorensen SM
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():25-32. PubMed ID: 7911139
    [No Abstract]   [Full Text] [Related]  

  • 23. Discontinued drugs in 2005: schizophrenia drugs.
    Kerwin R
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1487-95. PubMed ID: 17107275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ziprasidone. A new second-generation antipsychotic agent].
    Lublin HK
    Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
    [No Abstract]   [Full Text] [Related]  

  • 26. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin involvement in the metamorphosis of the hydroid Eudendrium racemosum.
    Zega G; Pennati R; Fanzago A; De Bernardi F
    Int J Dev Biol; 2007; 51(4):307-13. PubMed ID: 17554682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In review: medicinal chemistry. Drug development in the last year. Antipsychotics. 1].
    Eiden F; Lentzen H
    Pharm Unserer Zeit; 1996 Jan; 25(1):28-38. PubMed ID: 8882751
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biochemical effects of neuroleptics].
    Petit M; Dollfus S
    Encephale; 1990; 16(2):71-98. PubMed ID: 1972057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells.
    Cobos EJ; del Pozo E; Baeyens JM
    J Neurochem; 2007 Aug; 102(3):812-25. PubMed ID: 17419803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brain.
    Schmitt A; May B; Müller B; Jatzko A; Petroianu G; Braus DF; Henn FA
    Pharmacopsychiatry; 2003 Nov; 36(6):292-6. PubMed ID: 14663653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology.
    Sokoloff P; Martres MP; Giros B; Bouthenet ML; Schwartz JC
    Neurochem Int; 1992 Mar; 20 Suppl():27S-32S. PubMed ID: 1365440
    [No Abstract]   [Full Text] [Related]  

  • 33. Sigma receptors and sigma ligands: background to a pharmacological enigma.
    Leonard BE
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S166-70. PubMed ID: 15547782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
    Möller HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1101-11. PubMed ID: 14642970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT3 antagonists and ligands for dopamine D1- and autoreceptors offer new leads for antipsychotic drugs.
    Abbott A
    Trends Pharmacol Sci; 1990 Feb; 11(2):49-51. PubMed ID: 1969187
    [No Abstract]   [Full Text] [Related]  

  • 36. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
    Rammes G; Eisensamer B; Ferrari U; Shapa M; Gimpl G; Gilling K; Parsons C; Riering K; Hapfelmeier G; Bondy B; Zieglgänsberger W; Holsboer F; Rupprecht R
    Mol Psychiatry; 2004 Sep; 9(9):846-58, 818. PubMed ID: 15024394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.
    Tomić M; Kundaković M; Butorović B; Janać B; Andrić D; Roglić G; Ignjatović D; Kostić-Rajacić S
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4263-6. PubMed ID: 15261283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
    Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
    Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.